References

  1. Francque S, Vonghia L, Ramon A, Michielsen P. Epidemiology and treatment of autoimmune hepatitis. Hepatic Medicine. 2012;4:1-10. PubMed | Google Scholar

  2. Manns MP, Lohse AW, Vergani D. Autoimmune hepatitis update 2015. Journal of Hepatology. 2015;62(supplement 1): S100-S111. PubMed | Google Scholar

  3. Young NS. Current concepts in the pathophysiology and treatment of aplastic anemia. Hematology Am Soc Hematol Educ Program. 2013; 2013: 76-81. PubMed | Google Scholar

  4. Camitta BM, Thomas ED, Nathan DG. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976 Jul;48(1):63-70. PubMed | Google Scholar

  5. Lorenz E, Quaiser K. Panmyelopathie nach Hepatitis epidemica. Wien Med Wochenschr. 1955 Jan 8;105(1):19-22. PubMed | Google Scholar

  6. Gonzalez-Casas R, Garcia-Buey L, Jones EA, Gisbert JP, Moreno-Otero R. Systematic review: hepatitis-associated aplastic anaemia: a syndrome associated with abnormal immunological function. Aliment Pharmacol Ther. 2009;30(5):436-443. PubMed | Google Scholar

  7. Brown KE, Tisdale J, Barrett AJ, Dunbar CE,Young NS. Hepatitis-associated aplastic anemia. The New England Journal of Medicine. 1997;336(15): 1059-1064. PubMed | Google Scholar

  8. Cengiz C, Turhan N, Yolcu OF, Yilmaz S. Hepatitis associated with aplastic anemia: do CD8 (+) Kupffer cells have a role in the pathogenesis? Digestive Diseases and Sciences. 2007;52(9):2438-2443. PubMed | Google Scholar

  9. Savage WJ, DeRusso PA, Resar LM, Chen AR, Higman MA, Loeb DM et al. Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide. Pediatr Blood Cancer. 2007;49(7):947-951. PubMed | Google Scholar

  10. Doney K, Leisenring W, Storb R, Appelbaum FR. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team Ann Intern Med. 1997;126(2):107-115. PubMed | Google Scholar